Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Cancer Center, Peking University Cancer Hospital & Institute, People's Republic of China.
Oncologist. 2023 Apr 6;28(4):e183-e190. doi: 10.1093/oncolo/oyad010.
The diagnostic effectiveness of traditional imaging techniques is insufficient to assess the response of lymph nodes (LNs) to neoadjuvant chemotherapy (NAC), especially for pathological complete response (pCR). A radiomics model based on computed tomography (CT) could be helpful.
Prospective consecutive breast cancer patients with positive axillary LNs initially were enrolled, who received NAC prior to surgery. Chest contrast-enhanced thin-slice CT scan was performed both before and after the NAC (recorded as the first and the second CT respectively), and on both of them, the target metastatic axillary LN was identified and demarcated layer by layer. Using pyradiomics-based software that was independently created, radiomics features were retrieved. A pairwise machine learning workflow based on Sklearn (https://scikit-learn.org/) and FeAture Explorer was created to increase diagnostic effectiveness. An effective pairwise auto encoder model was developed by the improvement of data normalization, dimensionality reduction, and features screening scheme as well as the comparison of the prediction effectiveness of the various classifiers.
A total of 138 patients were enrolled, and 77 (58.7%) in the overall group achieved pCR of LN after NAC. Nine radiomics features were finally chosen for modeling. The AUCs of the training group, validation group, and test group were 0.944 (0.919-0.965), 0.962 (0.937-0.985), and 1.000 (1.000-1.000), respectively, and the corresponding accuracies were 0.891, 0.912, and 1.000.
The pCR of axillary LNs in breast cancer following NAC can be precisely predicted using thin-sliced enhanced chest CT-based radiomics.
传统影像学技术对评估新辅助化疗(NAC)后淋巴结(LNs)的反应的诊断效能不足,尤其是对病理完全缓解(pCR)的评估。基于 CT 的放射组学模型可能会有所帮助。
前瞻性连续入组了初始腋窝淋巴结阳性的乳腺癌患者,这些患者在手术前接受了 NAC。在 NAC 前后(分别记录为第一和第二次 CT)进行胸部增强薄层 CT 扫描,在这两次 CT 上,均逐层识别并勾画目标转移性腋窝 LN。使用自主研发的基于 pyradiomics 的软件提取放射组学特征。使用基于 Sklearn(https://scikit-learn.org/)和 Feature Explorer 的成对机器学习工作流来提高诊断效能。通过改进数据归一化、降维和特征筛选方案以及比较各种分类器的预测效能,开发了一种有效的成对自动编码器模型。
共入组 138 例患者,整体组中 77 例(58.7%)LN 经 NAC 后获得 pCR。最终选择了 9 个放射组学特征进行建模。训练组、验证组和测试组的 AUC 分别为 0.944(0.919-0.965)、0.962(0.937-0.985)和 1.000(1.000-1.000),相应的准确率分别为 0.891、0.912 和 1.000。
基于薄层增强胸部 CT 的放射组学可准确预测乳腺癌 NAC 后腋窝 LNs 的 pCR。